• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[珠状纤维素用于药物控释。5. 以苯佐卡因作为模型药物与二醛珠状纤维素的结合及其体外释放]

[The use of bead cellulose for controlled drug liberation. 5. Binding of benzocaine as a model drug to dialdehyde-bead cellulose and its in vitro liberation].

作者信息

Wolf B, Finke I

机构信息

Sektion Biowissenschaften, Lehrstuhl Pharmazeutische Technologie der Universität, Leipzig.

出版信息

Pharmazie. 1992 Feb;47(2):121-5.

PMID:1635919
Abstract

In the case of ionic binding of drugs to bead cellulose and its derivatives there was no pronounced retardation obvious. Because of this lack benzocaine as a model drug was covalent bound to dialdehyde bead cellulose by an azomethine bond in analogy with enzyme immobilisation methods. The rate of liberation in phosphate buffer was low and incomplete compared with the dissolution rate of pure benzocaine under the same conditions. A further decrease of liberation rate was obtained by reduction of the azomethine to the amine bond. Retardation of drug liberation strictly speaking was not achieved. The main amount of liberated drug was liberated during the first 20 min, but after 6 h the rate was still under 50% of the drug available. The physical properties of the beads like spherical shape and porosity are not significantly influenced by oxidation of cellulose and by loading with drug.

摘要

对于药物与珠状纤维素及其衍生物的离子结合情况,没有明显的显著阻滞现象。由于存在这种不足,作为模型药物的苯佐卡因通过与酶固定化方法类似的甲亚胺键共价结合到二醛珠状纤维素上。与相同条件下纯苯佐卡因的溶解速率相比,在磷酸盐缓冲液中的释放速率较低且不完全。通过将甲亚胺还原为胺键,释放速率进一步降低。严格来说,并未实现药物释放的阻滞。释放药物的主要部分在最初20分钟内释放,但6小时后释放速率仍低于可用药物的50%。珠状颗粒的物理性质,如球形形状和孔隙率,不受纤维素氧化和药物负载的显著影响。

相似文献

1
[The use of bead cellulose for controlled drug liberation. 5. Binding of benzocaine as a model drug to dialdehyde-bead cellulose and its in vitro liberation].[珠状纤维素用于药物控释。5. 以苯佐卡因作为模型药物与二醛珠状纤维素的结合及其体外释放]
Pharmazie. 1992 Feb;47(2):121-5.
2
[The use of bead cellulose for controlled drug liberation. 5. Kinetics of liberation of bonded drugs from bead cellulose and bead cellulose derivatives].[珠状纤维素用于药物控释。5. 结合药物从珠状纤维素和珠状纤维素衍生物中的释放动力学]
Pharmazie. 1992 Mar;47(3):204-7.
3
[The use of bead cellulose for controlled drug liberation. 4. Binding of bead cellulose and bead cellulose-derivatives with prazosin hydrochloride and its liberation].[用于药物控释的珠状纤维素。4. 珠状纤维素及其衍生物与盐酸哌唑嗪的结合及其释放]
Pharmazie. 1992 Jan;47(1):35-8.
4
[The use of bead cellulose for controlled drug liberation. 3. The ion exchange capacity of bead cellulose and bead cellulose derivatives].[用于药物控释的珠状纤维素。3. 珠状纤维素及珠状纤维素衍生物的离子交换容量]
Pharmazie. 1991 Dec;46(12):861-3.
5
Effect of surfactant on dissolution of spherical particles in micellar systems.表面活性剂对球形颗粒在胶束体系中溶解的影响。
Eur J Pharm Biopharm. 2007 Feb;65(2):188-97. doi: 10.1016/j.ejpb.2006.07.017. Epub 2006 Aug 11.
6
[Possibility of influencing drug release from polymers--using the example of bead polymers].
Pharmazie. 1983 Dec;38(12):860-4.
7
DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.DC微球:经动脉化疗栓塞给药装置的体外特性研究
J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):335-42. doi: 10.1097/01.RVI.0000195323.46152.B3.
8
[The effect of storage on drug content and release from polymerized beads].
Pharmazie. 1984 Mar;39(3):166-7.
9
[Interaction between macromolecular adjuvants and drugs. 25. The effect of cellulose ether on the solubility characteristics of benzodiazepine derivatives].
Pharmazie. 1986 Dec;41(12):845-9.
10
Porous soluble dialdehyde cellulose beads: A new carrier for the formulation of poorly water-soluble drugs.多孔溶性二醛纤维素珠:一种新的载体,用于制备水溶性差的药物。
Int J Pharm. 2022 Mar 5;615:121491. doi: 10.1016/j.ijpharm.2022.121491. Epub 2022 Jan 19.